• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主蛋白酶在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入过程中的作用。

Roles of host proteases in the entry of SARS-CoV-2.

作者信息

Zabiegala Alexandria, Kim Yunjeong, Chang Kyeong-Ok

机构信息

Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, 1800 Denison Avenue, Manhattan, KS 66506 USA.

出版信息

Anim Dis. 2023;3(1):12. doi: 10.1186/s44149-023-00075-x. Epub 2023 Apr 25.

DOI:10.1186/s44149-023-00075-x
PMID:37128508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10125864/
Abstract

The spike protein (S) of SARS-CoV-2 is responsible for viral attachment and entry, thus a major factor for host susceptibility, tissue tropism, virulence and pathogenicity. The S is divided with S1 and S2 region, and the S1 contains the receptor-binding domain (RBD), while the S2 contains the hydrophobic fusion domain for the entry into the host cell. Numerous host proteases have been implicated in the activation of SARS-CoV-2 S through various cleavage sites. In this article, we review host proteases including furin, trypsin, transmembrane protease serine 2 (TMPRSS2) and cathepsins in the activation of SARS-CoV-2 S. Many betacoronaviruses including SARS-CoV-2 have polybasic residues at the S1/S2 site which is subjected to the cleavage by furin. The S1/S2 cleavage facilitates more assessable RBD to the receptor ACE2, and the binding triggers further conformational changes and exposure of the S2' site to proteases such as type II transmembrane serine proteases (TTPRs) including TMPRSS2. In the presence of TMPRSS2 on the target cells, SARS-CoV-2 can utilize a direct entry route by fusion of the viral envelope to the cellular membrane. In the absence of TMPRSS2, SARS-CoV-2 enter target cells endosomes where multiple cathepsins cleave the S for the successful entry. Additional host proteases involved in the cleavage of the S were discussed. This article also includes roles of 3C-like protease inhibitors which have inhibitory activity against cathepsin L in the entry of SARS-CoV-2, and discussed the dual roles of such inhibitors in virus replication.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的刺突蛋白(S)负责病毒的附着和进入,因此是宿主易感性、组织嗜性、毒力和致病性的主要因素。S蛋白分为S1和S2区域,S1包含受体结合域(RBD),而S2包含用于进入宿主细胞的疏水融合域。许多宿主蛋白酶通过各种切割位点参与了SARS-CoV-2 S蛋白的激活。在本文中,我们综述了包括弗林蛋白酶、胰蛋白酶、跨膜蛋白酶丝氨酸2(TMPRSS2)和组织蛋白酶在内的宿主蛋白酶在SARS-CoV-2 S蛋白激活中的作用。包括SARS-CoV-2在内的许多β冠状病毒在S1/S2位点具有多碱性残基,可被弗林蛋白酶切割。S1/S2切割使RBD更容易与受体血管紧张素转换酶2(ACE2)结合,这种结合会触发进一步的构象变化,并使S2'位点暴露于包括TMPRSS2在内的II型跨膜丝氨酸蛋白酶(TTPPs)等蛋白酶。在靶细胞存在TMPRSS2的情况下,SARS-CoV-2可通过病毒包膜与细胞膜融合利用直接进入途径。在缺乏TMPRSS2的情况下,SARS-CoV-2进入靶细胞的内体,在那里多种组织蛋白酶切割S蛋白以实现成功进入。本文还讨论了参与S蛋白切割的其他宿主蛋白酶。本文还包括3C样蛋白酶抑制剂在SARS-CoV-2进入过程中对组织蛋白酶L的抑制活性的作用,并讨论了此类抑制剂在病毒复制中的双重作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8a/10125864/f82bbb7be011/44149_2023_75_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8a/10125864/4f939f1098d9/44149_2023_75_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8a/10125864/c5341abfbd0c/44149_2023_75_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8a/10125864/f82bbb7be011/44149_2023_75_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8a/10125864/4f939f1098d9/44149_2023_75_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8a/10125864/c5341abfbd0c/44149_2023_75_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8a/10125864/f82bbb7be011/44149_2023_75_Fig3_HTML.jpg

相似文献

1
Roles of host proteases in the entry of SARS-CoV-2.宿主蛋白酶在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入过程中的作用。
Anim Dis. 2023;3(1):12. doi: 10.1186/s44149-023-00075-x. Epub 2023 Apr 25.
2
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
3
Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.对人类蛋白酶对 SARS-CoV-2 刺突糖蛋白进行蛋白水解切割的能力进行全基因组生物信息学分析。
Microbiol Spectr. 2024 Feb 6;12(2):e0353023. doi: 10.1128/spectrum.03530-23. Epub 2024 Jan 8.
4
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.SARS-CoV-2 刺突蛋白的弗林蛋白酶裂解位点和 S2'碱性残基以宿主细胞依赖的方式调节进入过程。
J Virol. 2022 Jul 13;96(13):e0047422. doi: 10.1128/jvi.00474-22. Epub 2022 Jun 9.
5
A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.用于筛选针对 SARS-CoV-2 刺突糖蛋白基于胰蛋白酶样蛋白酶切割和病毒进入的药物的无细胞体外测定系统的底物。
J Med Virol. 2023 May;95(5):e28796. doi: 10.1002/jmv.28796.
6
Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.靶向丝氨酸蛋白酶抑制剂 B3 反应中心环突变体与 TMPRSS2 和 Furin:抑制 SARS-CoV-2 细胞进入和复制。
Int J Mol Sci. 2022 Oct 19;23(20):12522. doi: 10.3390/ijms232012522.
7
Proteolytic activation of SARS-CoV-2 spike protein.SARS-CoV-2 刺突蛋白的蛋白水解激活。
Microbiol Immunol. 2022 Jan;66(1):15-23. doi: 10.1111/1348-0421.12945. Epub 2021 Oct 12.
8
Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.中东呼吸综合征冠状病毒刺突蛋白潜在裂解位点的功能分析。
Sci Rep. 2018 Nov 9;8(1):16597. doi: 10.1038/s41598-018-34859-w.
9
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.SARS-CoV-2 刺突蛋白中的多碱性切割位点调节病毒对 I 型干扰素和 IFITM2 的敏感性。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.02422-20.
10
Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity.了解SARS-CoV-2刺突蛋白裂解位点中保守的脯氨酸和丝氨酸残基在病毒进入、融合和感染性中的作用。
3 Biotech. 2023 Oct;13(10):323. doi: 10.1007/s13205-023-03749-y. Epub 2023 Aug 30.

引用本文的文献

1
Synergistic activation of bat SARS-like coronaviruses spike protein by elastase and TMPRSS2.弹性蛋白酶和跨膜丝氨酸蛋白酶2对蝙蝠SARS样冠状病毒刺突蛋白的协同激活作用
Sci Rep. 2025 Jul 21;15(1):26469. doi: 10.1038/s41598-025-11600-y.
2
Host susceptibilities and entry processes of SARS-CoV-2 Omicron variants using pseudotyped viruses carrying spike protein.使用携带刺突蛋白的假型病毒研究SARS-CoV-2奥密克戎变体的宿主易感性和进入过程。
BMC Vet Res. 2025 May 27;21(1):377. doi: 10.1186/s12917-025-04822-9.
3
Association of VDR and TMPRSS2 gene polymorphisms with COVID-19 severity: a computational and clinical study.

本文引用的文献

1
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo.在体外用和体内比较 3CL 蛋白酶抑制剂恩赛特韦和奈玛特韦对 SARS-CoV-2 的疗效。
J Antimicrob Chemother. 2023 Apr 3;78(4):946-952. doi: 10.1093/jac/dkad027.
2
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review.甲磺酸萘莫司他治疗住院 COVID-19 患者:一项结构化、叙事性综述。
Clin Pharmacokinet. 2022 Oct;61(10):1331-1343. doi: 10.1007/s40262-022-01170-x. Epub 2022 Aug 30.
3
The Key Role of Lysosomal Protease Cathepsins in Viral Infections.
维生素D受体(VDR)和跨膜丝氨酸蛋白酶2(TMPRSS2)基因多态性与新型冠状病毒肺炎(COVID-19)严重程度的关联:一项计算与临床研究
Mol Biol Rep. 2025 Mar 19;52(1):327. doi: 10.1007/s11033-025-10417-2.
4
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry.SARS-CoV-2 奥密克戎亚变种逐渐适应宿主细胞进入机制改变的人类细胞。
mSphere. 2024 Sep 25;9(9):e0033824. doi: 10.1128/msphere.00338-24. Epub 2024 Aug 27.
5
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function.抑肽酶(I):了解宿主蛋白酶在 COVID-19 中的作用及药理调节其功能的重要性。
Int J Mol Sci. 2024 Jul 10;25(14):7553. doi: 10.3390/ijms25147553.
6
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.抑肽酶(II):用于治疗 COVID-19 和其他病毒病的吸入式给药。
Int J Mol Sci. 2024 Jun 29;25(13):7209. doi: 10.3390/ijms25137209.
7
Kinetics of SARS-CoV-2 infection biomarkers in a household transmission study.家庭传播研究中 SARS-CoV-2 感染生物标志物的动力学。
Sci Rep. 2024 May 29;14(1):12365. doi: 10.1038/s41598-024-62835-0.
8
Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking TLR4‑NFκB‑driven ACE2 and TMPRSS2 pathways.蒲公英根提取物和蒲公英甾醇通过阻断TLR4-NFκB驱动的ACE2和TMPRSS2途径抑制LPS诱导的结肠癌细胞活力。
Exp Ther Med. 2024 Apr 19;27(6):256. doi: 10.3892/etm.2024.12544. eCollection 2024 Jun.
9
Association of Renin-Angiotensin Pathway Gene Polymorphisms with COVID-19 Susceptibility and Severity in Moroccans: A Case-Control Study.肾素-血管紧张素途径基因多态性与摩洛哥人感染新冠病毒的易感性及严重程度的关联:一项病例对照研究
Biochem Genet. 2024 May 8. doi: 10.1007/s10528-024-10813-6.
10
Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.对人类蛋白酶对 SARS-CoV-2 刺突糖蛋白进行蛋白水解切割的能力进行全基因组生物信息学分析。
Microbiol Spectr. 2024 Feb 6;12(2):e0353023. doi: 10.1128/spectrum.03530-23. Epub 2024 Jan 8.
溶酶体蛋白酶组织蛋白酶在病毒感染中的关键作用。
Int J Mol Sci. 2022 Aug 13;23(16):9089. doi: 10.3390/ijms23169089.
4
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.SARS-CoV-2 奥密克戎是一种具有改变的细胞进入途径的免疫逃逸变体。
Nat Microbiol. 2022 Aug;7(8):1161-1179. doi: 10.1038/s41564-022-01143-7. Epub 2022 Jul 7.
5
Structure of Human TMPRSS2 in Complex with SARS-CoV-2 Spike Glycoprotein and Implications for Potential Therapeutics.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突糖蛋白结合的人跨膜丝氨酸蛋白酶2(TMPRSS2)的结构及其对潜在治疗方法的启示
J Phys Chem Lett. 2022 Jun 8:5324-5333. doi: 10.1021/acs.jpclett.2c00967.
6
Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies.在新冠病毒刺突蛋白中鉴定出的新型切割位点揭示了组织蛋白酶L促进病毒感染的机制及治疗策略。
Cell Discov. 2022 Jun 6;8(1):53. doi: 10.1038/s41421-022-00419-w.
7
Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.关注的 SARS-CoV-2 变异株刺突突变对人类或动物 ACE2 介导的病毒进入和中和的影响。
Microbiol Spectr. 2022 Jun 29;10(3):e0178921. doi: 10.1128/spectrum.01789-21. Epub 2022 May 31.
8
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease.基于结构的 SARS-CoV-2 3C 样蛋白酶强效螺环抑制剂设计。
J Med Chem. 2022 Jun 9;65(11):7818-7832. doi: 10.1021/acs.jmedchem.2c00224. Epub 2022 May 31.
9
An orally available M inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron.一种口服 M 抑制剂对野生型 SARS-CoV-2 及其变体(包括奥密克戎)有效。
Nat Microbiol. 2022 May;7(5):716-725. doi: 10.1038/s41564-022-01119-7. Epub 2022 Apr 27.
10
NETosis and SARS-COV-2 infection related thrombosis: a narrative review.中性粒细胞胞外诱捕网形成与新型冠状病毒肺炎感染相关血栓形成:一篇叙述性综述
Thromb J. 2022 Mar 30;20(1):13. doi: 10.1186/s12959-022-00375-1.